ATLANTA–(BUSINESS WIRE)–Shore Capital Partners (“Shore Capital”), a leading lower middle market healthcare private equity firm, is pleased to announce its portfolio company EyeSouth Partners (“EyeSouth” or the “Company”) has completed a strategic partnership with Georgia Retina, one of the largest retina medical practices in the Southeast.
“Our primary aim at Georgia Retina has always been to deliver exceptional medical and surgical retinal care combined with an outstanding patient experience,” said Dr. Michael Jacobson, who along with Dr. Scott Lampert founded Georgia Retina in 1994. “To further and build upon this mission in the rapidly changing healthcare environment, we have decided to enlist Shore Capital and EyeSouth as our partners to help us strengthen and expand our administrative and organizational structure.”
For over 20 years, Georgia Retina and its 13 board-certified ophthalmologists have offered first-class expertise in the treatment of diseases of the retina, macula, and vitreous to patients via 12 locations in the Atlanta metro area and throughout Georgia, including a strong commitment to providing care in underserved areas.
“Georgia Retina, EyeSouth and Shore Capital share similar cultural values,” said Dr. Atul Sharma, Managing Partner of Georgia Retina. “We are all committed to clinical excellence, increasing access to high quality care and providing our employees with opportunities for personal and professional growth. “We have a common vision of building a leading ophthalmology practice in the Southeast.”
“We are certain that Shore Capital and EyeSouth will enhance our ability to offer personalized cutting-edge care, the latest technologies, and expanding clinical research,” said Dr. Mark Rivellese of Georgia Retina. “We look forward to working together to better serve our patients throughout Georgia.”
Georgia Retina will continue to operate under its brand in the community with no changes to its physician base or locations. Paul Lucas, CFO and Administrator of Georgia Retina, will continue to lead Georgia Retina as the President of EyeSouth’s Posterior (retina) Division.
“In the early days of forming EyeSouth, it was clear to us that Georgia Retina had a reputation in Georgia and the Southeast for leading clinical quality that aligned well with EyeSouth’s culture and vision,” said Justin Ishbia, Managing Partner at Shore Capital. “We are very excited to partner with the Georgia Retina physicians, Paul and their team as we continue to build a premier network of medical and surgical eye care services in Georgia and the Southeast.”
EyeSouth previously completed an affiliation with Georgia Eye Partners in February 2017. EyeSouth’s affiliate network consists of 26 doctors providing medical and surgical eye care services at 17 locations in Georgia.
About Georgia Retina
Headquartered in Atlanta, GA with 12 locations, Georgia Retina is one of the largest retina-only medical practices in the southeastern U.S. For over 20 years, Georgia Retina’s board-certified ophthalmologists have been offering first-class expertise in the treatment of diseases of the retina, macula and vitreous.
About EyeSouth Partners
Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care services organization committed to partnering with leading physicians to build a premier network of eye care services in Georgia and the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with capital, administrative resources, operating expertise, and strategic guidance with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of 26 doctors practicing at 17 locations in Georgia.
About Shore Capital Partners
Shore Capital Partners (“Shore Capital”) is a Chicago-based private equity firm focused exclusively on microcap healthcare investments. Shore Capital supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore Capital targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore Capital has approximately $350 million of equity capital under management through various investment vehicles.
Zachary Tramonti, 617-391-0797